• Explore /
  • Poster
  • / Using circulating tumor DNA (ctDNA) to predict surgical outcome and postoperative recurrence following neoadjuvant chemoradiation (CRT) for borderline resectable/locally advanced rectal cancer (LARC).

Using circulating tumor DNA (ctDNA) to predict surgical outcome and postoperative recurrence following neoadjuvant chemoradiation (CRT) for borderline resectable/locally advanced rectal cancer (LARC).

Abstract Poster

Authors

null

Susan G.R. McDuff

Harvard Radiation Oncology Program - Massachusetts General Hospital, Boston, MA

Susan G.R. McDuff , Karin Hardiman , Aparna Raj Parikh , Peter Ulintz , Mehlika Hazar-Rethinam , Hui Zheng , Emily Van Seventer , Isobel Fetter , Brandon Nadres , David P. Ryan , Colin D. Weekes , Jeffrey W. Clark , James C. Cusack , Lipika Goyal , Andrew X. Zhu , Jennifer Yon-Li Wo , Lawrence Scott Blaszkowsky , Jill N. Allen , Theodore S. Hong , Ryan Bruce Corcoran

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 562)

DOI

10.1200/JCO.2019.37.4_suppl.562

Abstract #

562

Poster Bd #

G5

Abstract Disclosures

Similar Posters

First Author: Jeanne Tie

First Author: Zhenyu Lin

First Author: Christina Sing-Ying Wu

First Author: D. Helbling